VIBLIOME
Vibliome has discovered a new systematic approach that enables the development of small molecule kinase inhibitors with unique selectivity profiles and, in some cases, extraordinary selectivity. There are over 500 kinases in the human genome which control nearly all cellular functions by transferring a polar phosphate group from ATP to regulatory serine, threonine, or tyrosine residues on proteins. The versatility of our chemistry platform offers many opportunities for variation while maintaining a common general architecture.
VIBLIOME
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Bozeman, Montana, United States
Country:
United States
Website Url:
http://www.vibliome.com
Total Employee:
1+
Status:
Active
Contact:
(406) 595-3483
Total Funding:
46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving Apache
Similar Organizations
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Current Employees Featured
Founder
Investors List
Deerfield
Deerfield investment in Series A - Vibliome
Official Site Inspections
http://www.vibliome.com Semrush global rank: 4.46 M Semrush visits lastest month: 2.45 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
